The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Nuclear Medicine-Global Market Insights and Sales Trends 2025
Synopsis
Nuclear Medicine，or Radiopharmaceuticals， are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.
The global Nuclear Medicine market size is expected to reach US$ 10260 million by 2029, growing at a CAGR of 7.4% from 2023 to 2029. The market is mainly driven by the significant applications of Nuclear Medicine in various end use industries. The expanding demands from the Diagnostic and Therapeutic, are propelling Nuclear Medicine market. Tc-99, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the I-123/131 segment is estimated at % CAGR for the next seven-year period.
North America is the largest consumption area, with a consumption market share nearly 50%. Following North America, Europe is the second place consumption region with the consumption market share of about 25%.
Global Nuclear Medicine key manufacturers include GE Healthcare, Bracco Imaging, etc. The global top 2 manufacturers account for over 30 percent of total share.
The classification of Nuclear Medicine includes Tc-99, I-123/131, In-111, Xe-133, Th-201 and Ga-67, and the proportion of Tc-99 is about 50%.
Nuclear Medicine is widely used in Diagnostic, Therapeutic. The most proportion of Nuclear Medicine is Diagnostic, and the market share is over 60%.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Nuclear Medicine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Nuclear Medicine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Nuclear Medicine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Nuclear Medicine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Nuclear Medicine covered in this report include GE Healthcare, Bracco Imaging, Mallinckrodt, Lantheus Medical Imaging, Bayer, Triad Isotopes, Nordion, Jubilant Pharma and Eli Lilly, etc.
The global Nuclear Medicine market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
GE Healthcare
Bracco Imaging
Mallinckrodt
Lantheus Medical Imaging
Bayer
Triad Isotopes
Nordion
Jubilant Pharma
Eli Lilly
SIEMENS
China Isotope & Radiation
Dongcheng
Global Nuclear Medicine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Nuclear Medicine market, Segment by Type:
Tc-99
I-123/131
In-111
Xe-133
Th-201
Ga-67
Others
Global Nuclear Medicine market, by Application
Diagnostic
Therapeutic
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Nuclear Medicine companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Nuclear Medicine，or Radiopharmaceuticals， are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.
The global Nuclear Medicine market size is expected to reach US$ 10260 million by 2029, growing at a CAGR of 7.4% from 2023 to 2029. The market is mainly driven by the significant applications of Nuclear Medicine in various end use industries. The expanding demands from the Diagnostic and Therapeutic, are propelling Nuclear Medicine market. Tc-99, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the I-123/131 segment is estimated at % CAGR for the next seven-year period.
North America is the largest consumption area, with a consumption market share nearly 50%. Following North America, Europe is the second place consumption region with the consumption market share of about 25%.
Global Nuclear Medicine key manufacturers include GE Healthcare, Bracco Imaging, etc. The global top 2 manufacturers account for over 30 percent of total share.
The classification of Nuclear Medicine includes Tc-99, I-123/131, In-111, Xe-133, Th-201 and Ga-67, and the proportion of Tc-99 is about 50%.
Nuclear Medicine is widely used in Diagnostic, Therapeutic. The most proportion of Nuclear Medicine is Diagnostic, and the market share is over 60%.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Nuclear Medicine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Nuclear Medicine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Nuclear Medicine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Nuclear Medicine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Nuclear Medicine covered in this report include GE Healthcare, Bracco Imaging, Mallinckrodt, Lantheus Medical Imaging, Bayer, Triad Isotopes, Nordion, Jubilant Pharma and Eli Lilly, etc.
The global Nuclear Medicine market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
GE Healthcare
Bracco Imaging
Mallinckrodt
Lantheus Medical Imaging
Bayer
Triad Isotopes
Nordion
Jubilant Pharma
Eli Lilly
SIEMENS
China Isotope & Radiation
Dongcheng
Global Nuclear Medicine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Nuclear Medicine market, Segment by Type:
Tc-99
I-123/131
In-111
Xe-133
Th-201
Ga-67
Others
Global Nuclear Medicine market, by Application
Diagnostic
Therapeutic
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Nuclear Medicine companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Nuclear Medicine
1.1 Nuclear Medicine Market Overview
1.1.1 Nuclear Medicine Product Scope
1.1.2 Nuclear Medicine Market Status and Outlook
1.2 Global Nuclear Medicine Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Nuclear Medicine Market Size by Region (2018-2029)
1.4 Global Nuclear Medicine Historic Market Size by Region (2018-2023)
1.5 Global Nuclear Medicine Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Nuclear Medicine Market Size (2018-2029)
1.6.1 North America Nuclear Medicine Market Size (2018-2029)
1.6.2 Europe Nuclear Medicine Market Size (2018-2029)
1.6.3 Asia-Pacific Nuclear Medicine Market Size (2018-2029)
1.6.4 Latin America Nuclear Medicine Market Size (2018-2029)
1.6.5 Middle East & Africa Nuclear Medicine Market Size (2018-2029)
2 Nuclear Medicine Market by Type
2.1 Introduction
2.1.1 Tc-99
2.1.2 I-123/131
2.1.3 In-111
2.1.4 Xe-133
2.1.5 Th-201
2.1.6 Ga-67
2.1.7 Others
2.2 Global Nuclear Medicine Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Nuclear Medicine Historic Market Size by Type (2018-2023)
2.2.2 Global Nuclear Medicine Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Nuclear Medicine Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Nuclear Medicine Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Nuclear Medicine Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Nuclear Medicine Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Nuclear Medicine Revenue Breakdown by Type (2018-2029)
3 Nuclear Medicine Market Overview by Application
3.1 Introduction
3.1.1 Diagnostic
3.1.2 Therapeutic
3.2 Global Nuclear Medicine Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Nuclear Medicine Historic Market Size by Application (2018-2023)
3.2.2 Global Nuclear Medicine Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Nuclear Medicine Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Nuclear Medicine Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Nuclear Medicine Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Nuclear Medicine Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Nuclear Medicine Revenue Breakdown by Application (2018-2029)
4 Nuclear Medicine Competition Analysis by Players
4.1 Global Nuclear Medicine Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Nuclear Medicine as of 2022)
4.3 Date of Key Players Enter into Nuclear Medicine Market
4.4 Global Top Players Nuclear Medicine Headquarters and Area Served
4.5 Key Players Nuclear Medicine Product Solution and Service
4.6 Competitive Status
4.6.1 Nuclear Medicine Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 GE Healthcare
5.1.1 GE Healthcare Profile
5.1.2 GE Healthcare Main Business
5.1.3 GE Healthcare Nuclear Medicine Products, Services and Solutions
5.1.4 GE Healthcare Nuclear Medicine Revenue (US$ Million) & (2018-2023)
5.1.5 GE Healthcare Recent Developments
5.2 Bracco Imaging
5.2.1 Bracco Imaging Profile
5.2.2 Bracco Imaging Main Business
5.2.3 Bracco Imaging Nuclear Medicine Products, Services and Solutions
5.2.4 Bracco Imaging Nuclear Medicine Revenue (US$ Million) & (2018-2023)
5.2.5 Bracco Imaging Recent Developments
5.3 Mallinckrodt
5.3.1 Mallinckrodt Profile
5.3.2 Mallinckrodt Main Business
5.3.3 Mallinckrodt Nuclear Medicine Products, Services and Solutions
5.3.4 Mallinckrodt Nuclear Medicine Revenue (US$ Million) & (2018-2023)
5.3.5 Lantheus Medical Imaging Recent Developments
5.4 Lantheus Medical Imaging
5.4.1 Lantheus Medical Imaging Profile
5.4.2 Lantheus Medical Imaging Main Business
5.4.3 Lantheus Medical Imaging Nuclear Medicine Products, Services and Solutions
5.4.4 Lantheus Medical Imaging Nuclear Medicine Revenue (US$ Million) & (2018-2023)
5.4.5 Lantheus Medical Imaging Recent Developments
5.5 Bayer
5.5.1 Bayer Profile
5.5.2 Bayer Main Business
5.5.3 Bayer Nuclear Medicine Products, Services and Solutions
5.5.4 Bayer Nuclear Medicine Revenue (US$ Million) & (2018-2023)
5.5.5 Bayer Recent Developments
5.6 Triad Isotopes
5.6.1 Triad Isotopes Profile
5.6.2 Triad Isotopes Main Business
5.6.3 Triad Isotopes Nuclear Medicine Products, Services and Solutions
5.6.4 Triad Isotopes Nuclear Medicine Revenue (US$ Million) & (2018-2023)
5.6.5 Triad Isotopes Recent Developments
5.7 Nordion
5.7.1 Nordion Profile
5.7.2 Nordion Main Business
5.7.3 Nordion Nuclear Medicine Products, Services and Solutions
5.7.4 Nordion Nuclear Medicine Revenue (US$ Million) & (2018-2023)
5.7.5 Nordion Recent Developments
5.8 Jubilant Pharma
5.8.1 Jubilant Pharma Profile
5.8.2 Jubilant Pharma Main Business
5.8.3 Jubilant Pharma Nuclear Medicine Products, Services and Solutions
5.8.4 Jubilant Pharma Nuclear Medicine Revenue (US$ Million) & (2018-2023)
5.8.5 Jubilant Pharma Recent Developments
5.9 Eli Lilly
5.9.1 Eli Lilly Profile
5.9.2 Eli Lilly Main Business
5.9.3 Eli Lilly Nuclear Medicine Products, Services and Solutions
5.9.4 Eli Lilly Nuclear Medicine Revenue (US$ Million) & (2018-2023)
5.9.5 Eli Lilly Recent Developments
5.10 SIEMENS
5.10.1 SIEMENS Profile
5.10.2 SIEMENS Main Business
5.10.3 SIEMENS Nuclear Medicine Products, Services and Solutions
5.10.4 SIEMENS Nuclear Medicine Revenue (US$ Million) & (2018-2023)
5.10.5 SIEMENS Recent Developments
5.11 China Isotope & Radiation
5.11.1 China Isotope & Radiation Profile
5.11.2 China Isotope & Radiation Main Business
5.11.3 China Isotope & Radiation Nuclear Medicine Products, Services and Solutions
5.11.4 China Isotope & Radiation Nuclear Medicine Revenue (US$ Million) & (2018-2023)
5.11.5 China Isotope & Radiation Recent Developments
5.12 Dongcheng
5.12.1 Dongcheng Profile
5.12.2 Dongcheng Main Business
5.12.3 Dongcheng Nuclear Medicine Products, Services and Solutions
5.12.4 Dongcheng Nuclear Medicine Revenue (US$ Million) & (2018-2023)
5.12.5 Dongcheng Recent Developments
6 North America
6.1 North America Nuclear Medicine Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Nuclear Medicine Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Nuclear Medicine Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Nuclear Medicine Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Nuclear Medicine Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Nuclear Medicine Market Dynamics
11.1 Nuclear Medicine Industry Trends
11.2 Nuclear Medicine Market Drivers
11.3 Nuclear Medicine Market Challenges
11.4 Nuclear Medicine Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
